Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2026-04-02 @ 2:04 AM
Study NCT ID:
NCT06331832
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2024-03-26
First Post:
2024-03-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access of Imvotamab (IGM-2323) in Patients With R/R NHL
Sponsor:
Organization: